Bhlha15-CreERT2

Nomenclature

C57BL/6Smoc-Bhlha15em1(CreERT2)Smoc

Cat. NO.

NM-KI-200080

Strain State

Repository Live

Export PDF

Gene Summary

Gene Symbol
Bhlha15

Model Description

The coding region of Bhlha15 gene was replaced by a CreERT2 expression cassette.Besides,a kozak-CreERT2-WPRE-polyA expression cassette were knock into the Bhlha15 gene start codon site to generate Bhlha15-CreERT2(2)(Stock No. NM-KI-200158) mice. Bhlha15(basic helix-loop-helix family member a15) is also known as Mist1. The gene product is involved in controlling exocrine secretion from the pancreas, small intestine and stomach. When crossed with a strain carrying a gene flanked by loxP sites, the flanked gene will be removed in cells expressing Bhlha15.
Research Application:Cre recombinase tool, pancreatic acinar cells

Validation Data

image.png

Fig. 1 CreERT2-mediated recombination in the intestine of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the crypt of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse after tamoxifen treatment. 

image.png

Fig. 2 CreERT2-mediated recombination in the pancreas of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse. TdTomato(red) expression can be detected in the pancreas of Bhlha15CreERT2/+; Rosa26tdTomato/+ mouse after tamoxifen treatment. Some leakiness can be detected in the pancreas prior to tamoxifen treatment.

image.png

Fig. 3 Detection of tdTomato(red) in various tissues of Bhlha15CreERT2/+; Rosa26tdTomato/+ mice. Tdtomato is expressed in the pancreas, pituitary, stomach, crypt, salivary gland, lung, spleen, liver and kidney after tamoxifen treatment. Some leakiness can be detected in the salivary gland and pancreas prior to tamoxifen treatment. Tdtomato expression can not be observed in the brain, colon, heart, retina and skin. (For more detailed information please contact our technical advisor.)


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more